Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析

◆英語タイトル:Onxeo SA (ONXEO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2314590FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and prevention of radio chemotherapy, head cancer and neck cancer, among others. In addition, the company’s beleodaq acts as anti-cancer treatment for solid and hematology cancer. The company provides preclinical and clinical development, regulatory affairs and other services. It markets its products through its distribution network. Onxeo is headquartered in Paris, France.

Onxeo SA Key Recent Developments

Apr 08,2021: Onxeo to Present New Preclinical Data at AACR 2021
Mar 24,2021: Onxeo will publish its annual results on April 21, 2021
Feb 02,2021: Onxeo publishes letter to shareholders and provides update on its developments
Jan 28,2021: Onxeo obtains non-dilutive financing of 5 million Euros in the form of state guaranteed loans

This comprehensive SWOT profile of Onxeo SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Onxeo SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Onxeo SA – Key Information
Onxeo SA – Overview
Onxeo SA – Key Employees
Onxeo SA – Key Employee Biographies
Onxeo SA – Key Operational Heads
Onxeo SA – Major Products and Services
Onxeo SA – History
Onxeo SA – Company Statement
Onxeo SA – Locations And Subsidiaries
Onxeo SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Onxeo SA – Business Description
Onxeo SA – Corporate Strategy
Onxeo SA – SWOT Analysis
SWOT Analysis – Overview
Onxeo SA – Strengths
Onxeo SA – Weaknesses
Onxeo SA – Opportunities
Onxeo SA – Threats
Onxeo SA – Key Competitors

Section 3 – Company Financial Performance Charts

Onxeo SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Onxeo SA, Key Information
Onxeo SA, Key Ratios
Onxeo SA, Share Data
Onxeo SA, Major Products and Services
Onxeo SA, History
Onxeo SA, Key Employees
Onxeo SA, Key Employee Biographies
Onxeo SA, Key Operational Heads
Onxeo SA, Other Locations
Onxeo SA, Subsidiaries
Onxeo SA, Key Competitors
Onxeo SA, SWOT Analysis
Onxeo SA, Ratios based on current share price
Onxeo SA, Annual Ratios
Onxeo SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析
    AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CureMeta LLC-製薬・医療分野:企業M&A・提携分析
    Summary CureMeta LLC (CureMeta) is a biotechnology company that concentrates on the development of immunology therapeutics for cancers. The company advances novel antibody drug conjugates targeting pluripotent stem cells. Its pipeline product comprises Bstrongximab-ADC. CureMeta develops the antibod …
  • Samsung Electronics Co Ltd.:企業の戦略・SWOT・財務分析
    Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Beadell Resources Ltd:企業の戦略・SWOT・財務情報
    Beadell Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Beadell Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Celulose Irani S.A.:企業の戦略・SWOT・財務情報
    Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report Summary Celulose Irani S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cullen Resources Ltd:企業の財務・戦略的SWOT分析
    Summary Cullen Resources Ltd (Cullen) is a mining company that offers mineral exploration solutions. The company carries out the business of acquisition, exploration, and development of copper, iron, gold, and nickel properties. Its projects include West Pilbara Iron Ore project, Wyloo project, West …
  • Silver Spring Networks, Inc. (SSNI)-エネルギー分野:企業M&A・提携分析
    Summary Silver Spring Networks, Inc. (Silver Spring) is a smart grid networking platform technology and solutions provider. The company’s products include metering devices, network infrastructure, utilityIQ applications, GridScape software and customerIQ web portal. Silver Spring provides wide range …
  • Lear Corp (LEA):企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Casino Guichard-Perrachon SA:企業のM&A・事業提携・投資動向
    Casino Guichard-Perrachon SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Casino Guichard-Perrachon SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • NeuroPace Inc-医療機器分野:企業M&A・提携分析
    Summary NeuroPace Inc (NeuroPace) is a medical device company that designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. The company’s products include cutting edge medical devices, RNS systems, patient data management systems, magnet products, …
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Basin Electric Power Cooperative:企業の戦略・SWOT・財務分析
    Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report Summary Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Mediware Information Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • United States Cellular Corp (USM):企業の財務・戦略的SWOT分析
    United States Cellular Corp (USM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • E. Bon Holdings Limited (599):企業の財務・戦略的SWOT分析
    E. Bon Holdings Limited (599) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ASB Bank Limited:企業の戦略・SWOT・財務情報
    ASB Bank Limited - Strategy, SWOT and Corporate Finance Report Summary ASB Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nippon Shinyaku Co Ltd (4516):企業の財務・戦略的SWOT分析
    Nippon Shinyaku Co Ltd (4516) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆